Hyperprolactinemia and atypical antipsychotic therapy in a case of fatal thromboembolism

Journal of Clinical Psychopharmacology

Volumn 30, Issue 6, 2010, Pages 734-735

  Rousseau, Anne Marie ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; LOXAPINE; NORTRIPTYLINE; OLANZAPINE; RISPERIDONE; VENLAFAXINE;

ADULT; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ELECTROCONVULSIVE THERAPY; FATALITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERPROLACTINEMIA; LETTER; LUNG EMBOLISM; MAJOR DEPRESSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; SECONDARY AMENORRHEA; SIDE EFFECT; THROMBOEMBOLISM;

ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; HYPERPROLACTINEMIA; PSYCHOTIC DISORDERS; THROMBOEMBOLISM; YOUNG ADULT;

EID: 78649343881     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181fbbb69     Document Type: Letter

References (10)

1. Hamanaka S, Kamijo Y, Nagai T, et al. Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics. Circ J. 2004;68:850-852.
2. Jönsson AK, Brudin L, Ahlner J, et al. Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series. Int Clin Psychopharmacol. 2008;23: 263-268.
3. Landry P, Rousseau AM, Skalli L. Adverse effects of antipsychotics. In: Hertzman M, Adler L, eds. Chichester, UK: John Wiley and Sons, Ltd; 2010:337-380.
4. Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8:537-547.
5. Urban A, Masopust J, Maly R, et al. Prolactin as a factor for increased platelet aggregation. Neuroendocrinol Lett. 2007;28: 518-523.
6. Parkin L, Skegg DC, Herbison GP, et al. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003;12:647-652.
7. Axelsson S, Hagg S, Eriksson AC, et al. In vitro effects of antipsychotics on human platelet aggregation and plasma coagulation. Clin Exp Pharmacol Physiol. 2007;34: 775-780.
8. Borras L, Eytan A, de Timary P, et al. Pulmonary thromboembolism associated with olanzapine and risperidone. J Emerg Med. 2008;35:159-161.
9. Kamijo Y, Soma K, Nagai T, et al. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ J. 2003;67:46-48.
10. Liperoti R, Pedone C, Lapane KL, et al. Venous thromboembolism among elderly patients treated with atypical and first-generation antipsychotic agents. Arch Intern Med. 2005;165:2677-2682.